The following is the summary of “Is regular in-person recall superior to non-regular in-person recall in clinical outcomes among new patients undergoing peritoneal dialysis” published in the November 2022 issue of Renal failure by Liu, et al,
The purpose of this study is to explore the varied influences on clinical outcomes that are caused by frequent recall versus non-regular recall among incident peritoneal dialysis (PD) patients. Between January 1, 2013, and December 31, 2014, a cohort of 216 newly diagnosed PD patients was investigated at 2 different centers. Informative clinical data were collected from the beginning of the study until 2 years after PD treatment had been initiated. This data included demographics, laboratory, and PD-related parameters, rates of PD-related peritonitis, and the frequency with which patients were hospitalized.
Non-regular in-person recall (NRPR) was described as an interval spanning from more than one month to less than 3 months, while regular in-person recall (RPR) was defined as having an interval of 1 month. Patients in the NRPR group had a considerably higher percentage of patients diagnosed with peritonitis compared to patients in the RPR group (27.7% vs. 16.5%, P=.049). This difference was statistically significant. In the NRPR cohorts, the rate of PD-related peritonitis was significantly greater than in the RPR cohorts (0.16 vs. 0.09 person/year, P=.019).
Over the course of 2 years, the frequency of hospitalization due to Parkinson’s disease was also greater in the NRPR cohort (0.8 ± 1.0 vs. 0.5 ± 0.9, P=.039). The ratio of Kt/V in the NRPR cohort gradually fell over the course of two years, reaching levels that were lower than those in the RPR cohort. People newly diagnosed with Parkinson’s disease who had NRPR had much greater rates of PD-related peritonitis and required hospitalization more frequently than patients who had RPR.
Source: tandfonline.com/doi/full/10.1080/0886022X.2022.2145972